Purple Biotech Ltd (TLV:PPBT)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
Oct 20, 2026, 11:21 AM IDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 32.42 million as of October 23, 2026. It is the 41,236th most valuable company in the world and the 440th biggest in Israel. Its market cap has increased by 63.08% in one year.
Market Cap
32.42M
Enterprise Value
14.46M
Revenue
n/a
Global Rank
Country Rank
#440 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 32.42M, an increase of 81.38%. That is a compound annual growth rate of 4.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 32.42M | 45.37% |
| Dec 31, 2025 | 22.30M | -44.71% |
| Dec 31, 2024 | 40.34M | -48.30% |
| Dec 31, 2023 | 78.02M | -17.30% |
| Dec 29, 2022 | 94.35M | -55.64% |
| Dec 30, 2021 | 212.71M | -1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 209.10M |
| Matricelf | 82.54M |
| BioLineRx | 35.84M |
| Clal Biotechnology Industries | 34.51M |
| BioLight Life Sciences | 26.55M |
| XTL Biopharmaceuticals | 19.87M |
| Can-Fite BioPharma | 18.55M |
| Evogene | 18.42M |